Literature DB >> 35972650

Antifungal and Antibiofilm In Vitro Activities of Ursolic Acid on Cryptococcus neoformans.

Wen-Jing Wang1, Chan-Chan Liu2, Yan-Tong Li1, Miao-Qian Li1, Yu-Ting Fu1, Xin-Chen Li1, Wei-Dong Qian3,4.   

Abstract

Ursolic acid (UA) exists in a variety of medicinal plants. UA exhibits antimicrobial activity against several microorganisms; however, little is known regarding the potential antifungal effect of UA on Cryptococcus neoformans (C. neoformans). The antifungal and antibiofilm activities of UA on C. neoformans H99 were evaluated in this study. Minimum inhibitory concentration (MIC) of UA against C. neoformans H99 was determined by microdilution technique, and its action mode was elucidated by clarifying the variations in cell membrane integrity, capsule, and melanin production. Moreover, the inhibition and dispersal effects of UA on biofilm formation and mature biofilms by C. neoformans H99 were evaluated using crystal violet (CV) assay, optical microscopy, field emission scanning electron microscopy and confocal laser scanning microscopy. The results indicated that the MIC value of UA against C. neoformans H99 was 0.25 mg/mL. UA disrupted the cell membrane integrity, inhibited the capsule and melanin production of C. neoformans H99 in a concentration-dependent manner. Further, UA presented the inhibitory effect on biofilm formation and dispersed mature biofilms, as well as compromised the cell membrane integrity of C. neoformans H99 cells within biofilms. Together, these results indicate that UA might be a potential therapeutic option for the treatment of C. neoformans-related infections.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35972650     DOI: 10.1007/s00284-022-02992-5

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.343


  32 in total

Review 1.  A yeast under cover: the capsule of Cryptococcus neoformans.

Authors:  Indrani Bose; Amy J Reese; Jeramia J Ory; Guilhem Janbon; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2003-08

2.  Antibody-mediated immobilization of Cryptococcus neoformans promotes biofilm formation.

Authors:  Emma J Robertson; Arturo Casadevall
Journal:  Appl Environ Microbiol       Date:  2009-02-27       Impact factor: 4.792

Review 3.  The Cryptococcus neoformans capsule: a sword and a shield.

Authors:  Teresa R O'Meara; J Andrew Alspaugh
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 4.  Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.

Authors:  Benjamin J Park; Kathleen A Wannemuehler; Barbara J Marston; Nelesh Govender; Peter G Pappas; Tom M Chiller
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

5.  Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen.

Authors:  Nina Singh; Barbara D Alexander; Olivier Lortholary; Françoise Dromer; Krishan L Gupta; George T John; Ramon del Busto; Goran B Klintmalm; Jyoti Somani; G Marshall Lyon; Kenneth Pursell; Valentina Stosor; Patricia Muñoz; Ajit P Limaye; Andre C Kalil; Timothy L Pruett; Julia Garcia-Diaz; Atul Humar; Sally Houston; Andrew A House; Dannah Wray; Susan Orloff; Lorraine A Dowdy; Robert A Fisher; Joseph Heitman; Marilyn M Wagener; Shahid Husain
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

6.  Cases of disseminated cryptococcosis in intravenous drug abusers without HIV infection: A new risk factor?

Authors:  Mahmoud Shorman; Derek Evans; Christy Gibson; John Perfect
Journal:  Med Mycol Case Rep       Date:  2016-12-02

Review 7.  Basic principles of the virulence of Cryptococcus.

Authors:  Oscar Zaragoza
Journal:  Virulence       Date:  2019-12       Impact factor: 5.882

Review 8.  Treatment strategies for cryptococcal infection: challenges, advances and future outlook.

Authors:  Kali R Iyer; Nicole M Revie; Ci Fu; Nicole Robbins; Leah E Cowen
Journal:  Nat Rev Microbiol       Date:  2021-02-08       Impact factor: 60.633

9.  Proteomic profile of Cryptococcus neoformans biofilm reveals changes in metabolic processes.

Authors:  Lucélia Santi; Walter O Beys-da-Silva; Markus Berger; Diego Calzolari; Jorge A Guimarães; James J Moresco; John R Yates
Journal:  J Proteome Res       Date:  2014-01-27       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.